Skip to main content

Role of Lipids in Enhancing Splenic Uptake of Polymer-Lipid (LIPOMER) Nanoparticles

Buy Article:

$107.14 + tax (Refund Policy)

A number of intracellular infections are primarily resident in the spleen. The aim of present study was to evaluate the splenotropic potential of lipids reported in the preparation of solid lipid nanoparticles. A nanoparticulate system comprising of a hydrophilic polymer-lipid (LIPOMER) combination was selected. Nanoparticles of doxycycline hydrochloride, a highly water soluble drug and drug of choice for intracellular infections, were prepared by nanoprecipitation. Nanoparticles exhibited high drug entrapment efficiency and nanosize. Location of lipid in the nanoparticles was evaluated by transmission electron microscopy. Comparative biodistribution studies in rats, using 99mTc labeled formulations revealed enhanced splenic uptake of nanoparticles containing glyceryl monostearate as lipid. Further, the organ associated radioactivity of liver and spleen suggested significant enhancement in splenic uptake at concentrations of glyceryl monostearate (≥25%). Our findings suggest the splenotropic potential of glyceryl monostearate which could have ramifications for delivery of a number of agents to the spleen.

Keywords: DOXYCYCLINE HYDROCHLORIDE; GLYCERYL MONOSTEARATE; LIPIDS; POLYMERIC NANOPARTICLES; SCINTIGRAPHY; SPLENIC UPTAKE

Document Type: Research Article

Publication date: 01 September 2008

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content